Email Us
View Reports

Thermo Fisher Scientific Inc. Company Profile - Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

  • ID : 6368002  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 34   |  
  • Publisher : Market Data Forecast

Thermo Fisher Scientific Inc. (Thermo Fisher Scientific or 'the company') develops, manufactures, and provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company's serves more than 400,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings. The company has operations in 50 countries including the US, China, Germany, the UK, and other countries.

The company offer products and services under five principal brands which include: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. It operates through four business segments: laboratory products and services; life sciences solutions; specialty diagnostics; and analytical instruments.

The laboratory products and services segment offers self-manufactured and sourced products and extensive service needed for the laboratory. This segment serves the pharmaceutical, biotechnology, academic, government, research and industrial markets and clinical laboratory through four key businesses: laboratory equipment, laboratory consumables, research and safety market channel, and biopharma services.

The laboratory equipment includes equipment, accessories, and services for sample preparation, storage and protection, and analysis, mostly used by pharmaceutical companies for drug discovery and development and by biotechnology companies and universities for life science research. The products included in this category are sample preparation and preservation equipment such as incubators, cold storage equipment such as laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, centrifugation products such as microcentrifuges, biological safety cabinets, temperature control products, and water analysis instruments.

The laboratory consumables products include plastic, glass and related equipment, which customers use every day to support their scientific research, drug discovery and development, quality and process control, and clinical and basic research and development needs. This categories include cell culture and bioproduction products such as chamber slides, dishes, multidishes, flasks and gas permeable technologies; sample preparation and storage products; liquid handling products such as pipette tips; detection instruments such as microplate readers, washers, PCR (polymerase chain reaction) and qPCR (quantitative polymerase chain reaction) instruments and specialty products and services.

The research and safety market customer channel serves academic, pharmaceutical, biotechnology, government, and industrial customers. Fisher Science Education include educational and laboratory products for the K -12 and secondary education market. Doe & Ingalls offerings include chemical distribution and supply chain services to life science and technology manufacturers. BioPharma services offerings include global services for pharmaceutical and biotechnology companies engaged in clinical trials, including specialized packaging, over-encapsulation, multi-lingual and specialized labeling and distribution, biological-specimen management, specialty pharmaceutical logistics and clinical supply-chain planning and management.

Thermo Fisher Scientific's life sciences solutions segment provides an extensive portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The segment includes three primary businesses including biosciences; genetic, medical and applied sciences; and bio production.

The company's biosciences business includes reagents, instruments and consumables to conduct biological and medical research, discover new drugs and vaccines, and diagnose disease. The genetic, medical and applied sciences business combines a wide variety of instruments and related reagents used to analyze DNA across a broad range of applications in research, clinical and applied markets. The bio production business supports developers and manufacturers of biological-based therapeutics and vaccines with a portfolio of premium solutions and services focused on upstream cell culture, downstream purification, analytics for detection and quantitation of process/product impurities, and a suite of single-use solutions spanning the biologics workflow.

Through the specialty diagnostics segment, Thermo Fisher Scientific offers a range of diagnostic test kits, reagents, culture media, instruments and associated products in order to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. These healthcare products are used to increase the speed and accuracy of diagnoses. The segment has six primary businesses including clinical diagnostics, immunodiagnostics, microbiology, anatomical pathology, transplant diagnostics and healthcare market channel.

Immunodiagnostics offerings include developing, manufacturing and marketing complete blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The clinical diagnostics products include a broad offering of liquid, ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls and calibration verification fluids. The segment's transplant diagnostics products include human leukocyte antigen (HLA) typing and testing for the organ transplant market.

The company's microbiology offerings include dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products and associated products for the microbiology laboratory. The anatomical pathology offerings include a broad portfolio of products primarily for cancer diagnosis and medical research in histology, cytology and hematology applications. These products include a wide range of instruments, consumables and reagents for specimen collection and transport, tissue preparation, staining and immunohistochemistry assays and controls.

Thermo Fisher's healthcare market channel offerings include a broad array of consumables, diagnostic kits and reagents, equipment, instruments, solutions and services for hospitals, clinical laboratories, reference laboratories, physicians' offices and other clinical testing facilities. These products are manufactured by Thermo Fisher and third parties.

Thermo Fisher Scientific's analytical instruments segment provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field. This segment serves healthcare and diagnostics, pharmaceutical and biotechnology, academic and government and industrial, and clinical laboratory. The segment includes two primary businesses including chromatography and mass spectrometry, and chemical analysis.

The company's chromatography and mass spectrometry business provides analytical instrumentation for organic and inorganic sample analysis. The chromatography product line includes high performance liquid chromatography, ion chromatography and gas chromatography systems. The mass spectrometry product line includes life sciences mass spectrometry systems, inorganic mass spectrometry systems, elemental analysis instrumentation and sample preparation and separation products including auto-samplers and multiplexing systems. The chemical analysis products include five categories: materials and minerals; molecular spectroscopy; portable analytical instruments; and radiation measurement and security instruments; and environmental and process instruments.

Scope of the Report

-- About the Company - Historical Details, Current Ownership Structure and basic overview of Thermo Fisher Scientific Inc. in terms of revenue, net income, and operating income.

-- Financials - Details about Thermo Fisher Scientific Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.

-- Company SWOT Analysis - Outlines Thermo Fisher Scientific Inc.’s strengths, weaknesses, and opportunities and threats facing the company.

-- Recent Developments - Showcases Thermo Fisher Scientific Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

-- Strategic Evaluation - Provides an overview of Thermo Fisher Scientific Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

-- What domain does Thermo Fisher Scientific Inc. operate and what are key points about it?

-- What is the product / service portfolio of Thermo Fisher Scientific Inc.?

-- How has Thermo Fisher Scientific Inc. performed financially from the 2013?

-- How does Thermo Fisher Scientific Inc. rank among its peers in terms of revenue and market share?

-- What are Thermo Fisher Scientific Inc. strengths and weaknesses and what opportunities and threats does it face?

-- What are Thermo Fisher Scientific Inc.’s main growth strategies and how successful has the company been at implementing them?

-- What is the in-house technical capability of Thermo Fisher Scientific Inc.? Where does it procure / outsource it?

Reasons to buy

-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost

-- 12 hour delivery time fulfilling your urgent requests as per your requirement

-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics

1. About the Company

1.1 History and Basic Facts

1.2 Ownership Structure and Key Executives

1.3 Head Office

1.4 Other Locations & Subsidiaries

1.5 List of Competitors

1.6 Employee Count & Distribution

2. Financials

2.1 Company Type (Listed / Unlisted)

2.2 Annual Statements

2.3 Key Financial Highlights

2.4 Region-wise Breakdown

3. Product / Services

3.1 Overview

3.2 Description

4. SWOT Analysis

4.1 SWOT Overview

4.2 Strengths

4.3 Weaknesses

4.4 Opportunities

4.5 Threats

5. Recent Developments

5.1 Mergers & Acquisitions

5.2 Partnerships, Collaborations & Joint Ventures

5.3 New Product Launches

5.4 Business Expansion / Divestment

6. Strategic Evaluation

6.1 Corporate Strategy

6.2 Legal Issues

6.3 Analyst Outlook

7. Technology Landscape

7.1 Industry

-- 7.1.1 Industry Snapshot

-- 7.1.2 IT Spend

-- 7.1.3 Key Information Technology Trends

7.2 Company

-- 7.2.1 IT Overview

-- 7.2.2 Key IT Technologies

-- 7.2.3 Recent IT Initiatives

-- 7.2.4 IT Outsourcing Engagements

-- 7.2.5 Key IT Management

-- 7.2.6 CIO/CTO Profile


-- Methodology

-- About Us

-- Contact Us

-- Disclaimer

Fig.1: Company Snapshot

Fig.2: Locations Listing on Map

Table.1: Ownership Structure

Table.2: List of Competitors

Table.3: Annual Statements

Table.4: Key Financial Highlights

Table.5: Region-wise Breakdown

Table.6: Product/Services Overview

Table.7: Mergers & Acquisitions

Table.8: Partnerships, Collaborations & Joint Ventures

Table.9: New Product Launches

Table.10: Business Expansion / Divestment

Table 11: IT Budgets

Table 12: Key IT Management (CIO / CTO)

Table 13: IT Deals undertaken in the past years

Purchase this Market Research Report


Call us on : +1 888 709 8757

Drop us an email at :